The container orchestration platforms powering today's AI services handle increasingly sensitive intellectual property and ...

Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the ...

Feroskhan regards identity as the single immutable control surface in a cloud where networks dissolve into micro‑services.

Over 650 exhibitors joined a record crowd of nearly 44,000 attendees at RSAC 2025 this April to showcase their game-changing ...

Mayor Karen Bass’ proposed 2025-26 budget would include layoffs and eliminate vacant positions, in an effort to address an ...

CISA has flagged a critical-severity Commvault vulnerability as exploited one week after technical details were released.

Harmony Biosciences Holdings, Inc. ( NASDAQ: HRMY) Q1 2025 Earnings Call May 6, 2025 8:30 AM ET Brennan Doyle - Head, Investor Relations Jeffrey Dayno - President and Chief Executive Officer Adam ...

Enterprise VPN solutions are critical for connecting remote workers to company resources via reliable and secure links to ...

Q1 2025 Earnings Call Transcript May 1, 2025 X4 Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $4.0E-5, ...

Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...

Istaroxime also has a USPTO issued method of use patent providing protection until 2039 and a pending method of use patent providing protection until 2043. “We believe that the NCE exclusivity ...

Data from Phase 1b/2a RESOLVE suggests EP-104GI has significant potential to improve the standard of care for patients with Eosinophilic Esophagitis (EoE) Cash runway to fund operations out to third ...